Skip to content

Higher Cholesterol levels in blood.

A Randomised controlled trail to evaluate the efficacy of Ayurveda Intervention (Nitya Virechana)as an add-on to Standard Care in Secondary Hyperlipidemia. - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067265
Enrollment
60
Registered
2024-05-14
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E784- Other hyperlipidemia

Interventions

None listed

Sponsors

Nandini RD
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of all genders between the age group of 20-65 years who fulfil the criteria of Objective and Subjective parameters. 2.Controlled HTN -less than or equal to 140/90 mm of Hg. 3.Controlled NIDDM -HbA1C less than or equal to 7%. 4.Patients fulfilling the diagnostic criteria of Hyperlipidaemia. 5.Patients already on Antilipidemic drugs since 0-10years. 6.Patients fit for Nitya Virechana.

Exclusion criteria

Exclusion criteria: 1.Patients newly diagnosed and not on Antilipidemic drugs. 2.Induced Hyperlipidaemia due to prolonged intake of Glucocortiosteriods. 3.Patients suffering from major systemic illness necessitating long term drug treatment (Rheumatoid arthritis, Tuberculosis, Psycho-Neuro-Endocrinal disorders, CKD, Nephrotic Syndrome, Liver disorders etc.) 4.Patients with a past history of Atrial Fibrillation, Acute Coronary Syndrome, 5.Patient with evidence of malignancy. 6.Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Reduction in Cholesterol levelsTimepoint: 45days

Secondary

MeasureTime frame
Weight lossTimepoint: 45days

Countries

India

Contacts

Public ContactNandini RD

Ayurveda Mahavidhyalaya Hospital

padmavatikulkarni203@gmail.com9448235819

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026